Particle.news
Download on the App Store

Stiftung Warentest Says Most Cough Medicines Aren’t Worth the Money

The review points to weak evidence for popular syrups’ claims, guiding consumers toward simpler, lower-risk relief.

Overview

  • The independent tester evaluated study data for 27 over-the-counter products in its November 2025 issue.
  • All cough suppressants, herbal and synthetic, failed due to insufficient proof of efficacy.
  • Most expectorants were judged suitable only with limitations, with effects described as modest.
  • Some ingredients carry risks, including rare dependence and hallucinations reported with dextromethorphan.
  • Non-drug measures such as honey, warm drinks, lozenges and inhalation were recommended, and doctors note post-cold coughs often last three to four weeks.